inXso is glad to share our new partnership goals with BrainStormCorner, founded as a business think tank with global roots, born right next to Tampere University campus. BrainStormCorner is a versatile toolbox of business services and research commercialization, based on long international and multidisciplinary experience.

“While Finnish, we are extremely multilingual.”

With our common goals, inXso and BrainStormCorner will strive forwards to provide valuable insights for co-innovative solutions and international business development through upcoming collaboration offerings.

What to look forward to?

Through the partnership, both inXso and BrainStormCorner can provide a unique and in-depth insight into the international development of technology companies. We provide a platform for Finnish and foreign companies and start-ups. We help you to take the right steps towards building your business in Finland, or to develop your offering and expand abroad.

Our clients benefit from our multidisciplinary understanding of different technologies, as we speak both business and technology. We have long-standing international business insight in East Asia and Europe, which allows our clients to overcome barriers to market entry, identify business opportunities and provide practical solutions tailored to their needs.

Outstanding services currently available:

Companies and startups receive support for ideation, facilitation, engagement, project planning and hands-on experience for:

For very early stage entrepreneurs:

This support system is available for very early stage entrepreneurs in Tampere region. There are no restrictions for the company’s field of activity. Tailored, intensive and valuable business development packages are available for those individuals who send an application and are accepted into the program: Pirkanmaan Yrittäjyysbuusti, Pirkanmaa Entrepreneurial Boost – BrainStormCorner 

Learn more at BrainStormCorner

About inXso

Born internationally, we are helping innovators open up new lines of research and technology that are disrupting existing healthcare ecosystems.

inXso provides services in the healthcare sector with three focus areas:

EIC Internationalisation services

Internationalisation Services for EIC Beneficiaries in the Healthcare Sector

Internationalisation services for EIC beneficiaries in the healthcare sector are provided by inXso in the framework of the EIC Ecosystem Partnership.

inXso Joins SHIFT-HUB as an Official Partnership Organisation

inXso Joins SHIFT-HUB as an Official Partnership Organisation

inXso is delighted to announce our joining of an official partnership organisation with SHIFT-HUB, a pan-European Smart Health Innovation Hub.

Catalysing Breakthroughs in Deep Tech

Catalysing Breakthroughs in Deep Tech

The EIC Fund is uniquely positioned to finance innovations based on scientific discoveries or emerging technologies, catalysing breakthroughs in Deep Tech.

Beyond the Brain: The Role of Gut Health in Autism Spectrum Disorder

Beyond the Brain: The Role of Gut Health in Autism Spectrum Disorder

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterised by challenges in social interaction, communication, and repetitive behaviours.

International reimbursement

International Reimbursement Strategy for Orthopaedic Therapy Device

Leverage inXso’s expertise to create a successful reimbursement strategy and identify optimal countries regarding market introduction and revenue realisation.

Clinical Evaluation & Investigation

Clinical Evaluation & Investigation of Active Therapeutic Device

Case study to transit an active therapeutic device from the preclinical to the clinical phase using clinical design, development and regulatory considerations.

World Cancer Day

Conquering Cancer: Insights and Innovations from World Cancer Day 2024

Despite the surge of scientific and technological advancements in cancer prevention, diagnosis and treatment, cancer is the leading cause of death worldwide.

FDA Transition to ISO 13485 Regulatory Impact

FDA Transition to ISO 13485: Regulatory Impact

The FDA transition to ISO 13485 is a significant step in streamlining medical device manufacturers’ quality management systems for international operations.

Clinical Trials

Sponsors and Legal Representatives – Clinical Evaluation & Investigation under EU MDR 2017/745

The EU MDR 2017/745 regulation introduced a set of requirements for conducting clinical trials of medical devices and their sponsors and legal representatives.

FDA Regulatory Reform Outlook 2023

FDA Regulatory Reform Outlook 2023 focuses on the significant changes to the FDA regulatory framework and several initiatives that are waiting on the horizon.

Subscribe to our Newsletter to keep updated on latest opportunities!